With direct administration of a drug to a targeted organ during the development process for both small and large molecules, better control of dosing and limited systemic exposure can be achieved. MPI Research offers a wide range of targeted delivery options, using the following routes

  • Direct intestinal
  • Intrahepatic
  • Portal vein
  • Intramyocardial
  • Intra-aortic
  • Intraventricular
  • Intra-articular
  • Arterial/venous
  • Intravesicular (bladder)
  • Intrathecal/epidural
  • Organ-specific
  • Intracranial
  • Intraprostatic
  • Bile duct cannulation